Kelly Rea, Abigail Robbertz, Adrianna Westbrook, Jessica Buzenski, Bonney Reed
{"title":"一项随机对照试验:生物反馈增强认知行为疗法对青少年炎症性肠病的虚拟治疗","authors":"Kelly Rea, Abigail Robbertz, Adrianna Westbrook, Jessica Buzenski, Bonney Reed","doi":"10.1093/ibd/izaf061","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Inflammatory bowel diseases (IBDs) are increasingly recognized as products of the brain-gut axis associated with dysfunctions of the chronic stress response systems. The objectives of this study were to evaluate the feasibility, acceptability, and preliminary efficacy of a virtual, group-based heart rate variability (HRV) biofeedback-enhanced coping skills intervention for youth with IBD. Treatment targets included symptoms of anxiety, depression, gastrointestinal (GI) symptoms, and perceived stress.</p><p><strong>Methods: </strong>Youth with IBD (ages 13-18) and their caregivers were randomized to either immediate treatment or waitlist control groups. The intervention consisted of 6 virtually delivered, weekly group sessions combining cognitive-behavioral therapy (CBT) with HRV biofeedback training. Outcomes included measures of anxiety, depression, GI symptoms, perceived stress, and HRV parameters. Assessments were conducted at baseline and post-intervention.</p><p><strong>Results: </strong>Of the 53 youth randomized, 50 participated in their assigned group. The intervention demonstrated strong feasibility with 84% of participants attending at least 4 of 6 sessions. Both adolescents and parents reported strong satisfaction. Following treatment, parents reported significant decreases in adolescent depressive symptoms, anxiety symptoms, and GI symptoms compared to controls. Adolescents reported reductions in GI symptoms and perceived stress compared to controls and reductions in symptoms of anxiety within the treatment group. No changes were observed in HRV parameters.</p><p><strong>Conclusions: </strong>This pilot study supports the feasibility and acceptability of a virtual, group-based HRV biofeedback-enhanced coping skills intervention for youth with IBD. Preliminary efficacy was demonstrated for reducing psychological and physical symptoms. Future research should evaluate efficacy in a larger, more diverse sample with elevated baseline psychological symptoms.</p>","PeriodicalId":13623,"journal":{"name":"Inflammatory Bowel Diseases","volume":" ","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Biofeedback-Enhanced Cognitive-Behavioral Therapy Delivered Virtually to Youth With Inflammatory Bowel Disease: A Randomized Controlled Trial.\",\"authors\":\"Kelly Rea, Abigail Robbertz, Adrianna Westbrook, Jessica Buzenski, Bonney Reed\",\"doi\":\"10.1093/ibd/izaf061\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Inflammatory bowel diseases (IBDs) are increasingly recognized as products of the brain-gut axis associated with dysfunctions of the chronic stress response systems. The objectives of this study were to evaluate the feasibility, acceptability, and preliminary efficacy of a virtual, group-based heart rate variability (HRV) biofeedback-enhanced coping skills intervention for youth with IBD. Treatment targets included symptoms of anxiety, depression, gastrointestinal (GI) symptoms, and perceived stress.</p><p><strong>Methods: </strong>Youth with IBD (ages 13-18) and their caregivers were randomized to either immediate treatment or waitlist control groups. The intervention consisted of 6 virtually delivered, weekly group sessions combining cognitive-behavioral therapy (CBT) with HRV biofeedback training. Outcomes included measures of anxiety, depression, GI symptoms, perceived stress, and HRV parameters. Assessments were conducted at baseline and post-intervention.</p><p><strong>Results: </strong>Of the 53 youth randomized, 50 participated in their assigned group. The intervention demonstrated strong feasibility with 84% of participants attending at least 4 of 6 sessions. Both adolescents and parents reported strong satisfaction. Following treatment, parents reported significant decreases in adolescent depressive symptoms, anxiety symptoms, and GI symptoms compared to controls. Adolescents reported reductions in GI symptoms and perceived stress compared to controls and reductions in symptoms of anxiety within the treatment group. No changes were observed in HRV parameters.</p><p><strong>Conclusions: </strong>This pilot study supports the feasibility and acceptability of a virtual, group-based HRV biofeedback-enhanced coping skills intervention for youth with IBD. Preliminary efficacy was demonstrated for reducing psychological and physical symptoms. Future research should evaluate efficacy in a larger, more diverse sample with elevated baseline psychological symptoms.</p>\",\"PeriodicalId\":13623,\"journal\":{\"name\":\"Inflammatory Bowel Diseases\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2025-04-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Inflammatory Bowel Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/ibd/izaf061\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Inflammatory Bowel Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ibd/izaf061","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
Biofeedback-Enhanced Cognitive-Behavioral Therapy Delivered Virtually to Youth With Inflammatory Bowel Disease: A Randomized Controlled Trial.
Background: Inflammatory bowel diseases (IBDs) are increasingly recognized as products of the brain-gut axis associated with dysfunctions of the chronic stress response systems. The objectives of this study were to evaluate the feasibility, acceptability, and preliminary efficacy of a virtual, group-based heart rate variability (HRV) biofeedback-enhanced coping skills intervention for youth with IBD. Treatment targets included symptoms of anxiety, depression, gastrointestinal (GI) symptoms, and perceived stress.
Methods: Youth with IBD (ages 13-18) and their caregivers were randomized to either immediate treatment or waitlist control groups. The intervention consisted of 6 virtually delivered, weekly group sessions combining cognitive-behavioral therapy (CBT) with HRV biofeedback training. Outcomes included measures of anxiety, depression, GI symptoms, perceived stress, and HRV parameters. Assessments were conducted at baseline and post-intervention.
Results: Of the 53 youth randomized, 50 participated in their assigned group. The intervention demonstrated strong feasibility with 84% of participants attending at least 4 of 6 sessions. Both adolescents and parents reported strong satisfaction. Following treatment, parents reported significant decreases in adolescent depressive symptoms, anxiety symptoms, and GI symptoms compared to controls. Adolescents reported reductions in GI symptoms and perceived stress compared to controls and reductions in symptoms of anxiety within the treatment group. No changes were observed in HRV parameters.
Conclusions: This pilot study supports the feasibility and acceptability of a virtual, group-based HRV biofeedback-enhanced coping skills intervention for youth with IBD. Preliminary efficacy was demonstrated for reducing psychological and physical symptoms. Future research should evaluate efficacy in a larger, more diverse sample with elevated baseline psychological symptoms.
期刊介绍:
Inflammatory Bowel Diseases® supports the mission of the Crohn''s & Colitis Foundation by bringing the most impactful and cutting edge clinical topics and research findings related to inflammatory bowel diseases to clinicians and researchers working in IBD and related fields. The Journal is committed to publishing on innovative topics that influence the future of clinical care, treatment, and research.